BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 23136040)

  • 1. Research results: preserving newborn blood samples.
    Lewis MH; Scheurer ME; Green RC; McGuire AL
    Sci Transl Med; 2012 Nov; 4(159):159cm12. PubMed ID: 23136040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Public attitudes regarding the use of residual newborn screening specimens for research.
    Botkin JR; Rothwell E; Anderson R; Stark L; Goldenberg A; Lewis M; Burbank M; Wong B
    Pediatrics; 2012 Feb; 129(2):231-8. PubMed ID: 22250018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Newborn bloodspot retention reinstated in Minnesota: practice expected to benefit larger newborn screening studies, public health, disease research.
    Am J Med Genet A; 2014 Sep; 164A(9):viii-ix. PubMed ID: 25125344
    [No Abstract]   [Full Text] [Related]  

  • 4. State laws regarding the retention and use of residual newborn screening blood samples.
    Lewis MH; Goldenberg A; Anderson R; Rothwell E; Botkin J
    Pediatrics; 2011 Apr; 127(4):703-12. PubMed ID: 21444595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Newborn dried blood spot screening: residual specimen storage issues.
    Therrell BL; Hannon WH
    Pediatrics; 2012 Feb; 129(2):365-6. PubMed ID: 22250020
    [No Abstract]   [Full Text] [Related]  

  • 6. Lessons from the residual newborn screening dried blood sample litigation.
    Lewis MH
    J Law Med Ethics; 2015; 43 Suppl 1():32-5. PubMed ID: 25846160
    [No Abstract]   [Full Text] [Related]  

  • 7. Assessing public attitudes on the retention and use of residual newborn screening blood samples: a focus group study.
    Rothwell E; Anderson R; Goldenberg A; Lewis MH; Stark L; Burbank M; Wong B; Botkin JR
    Soc Sci Med; 2012 Apr; 74(8):1305-9. PubMed ID: 22398141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parental Consent for the Use of Residual Newborn Screening Bloodspots: Respecting Individual Liberty vs Ensuring Public Health.
    Bayefsky MJ; Saylor KW; Berkman BE
    JAMA; 2015 Jul; 314(1):21-2. PubMed ID: 26053685
    [No Abstract]   [Full Text] [Related]  

  • 9. Retention and research use of residual newborn screening bloodspots.
    Botkin JR; Goldenberg AJ; Rothwell E; Anderson RA; Lewis MH
    Pediatrics; 2013 Jan; 131(1):120-7. PubMed ID: 23209103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The view of Hong Kong parents on secondary use of dried blood spots in newborn screening program.
    Hui LL; Nelson EAS; Deng HB; Leung TY; Ho CH; Chong JSC; Fung GPG; Hui J; Lam HS
    BMC Med Ethics; 2022 Nov; 23(1):105. PubMed ID: 36319979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concerns of newborn blood screening advisory committee members regarding storage and use of residual newborn screening blood spots.
    Rothwell EW; Anderson RA; Burbank MJ; Goldenberg AJ; Lewis MH; Stark LA; Wong B; Botkin JR
    Am J Public Health; 2011 Nov; 101(11):2111-6. PubMed ID: 21330580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Citizens' values regarding research with stored samples from newborn screening in Canada.
    Bombard Y; Miller FA; Hayeems RZ; Carroll JC; Avard D; Wilson BJ; Little J; Bytautas JP; Allanson J; Axler R; Giguere Y; Chakraborty P
    Pediatrics; 2012 Feb; 129(2):239-47. PubMed ID: 22250019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Residual newborn screening samples for research: parental information needs for decision-making.
    Rothwell E; Clark L; Anderson R; Botkin JR
    J Spec Pediatr Nurs; 2013 Apr; 18(2):115-22. PubMed ID: 23560583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Committee report: Considerations and recommendations for national guidance regarding the retention and use of residual dried blood spot specimens after newborn screening.
    Therrell BL; Hannon WH; Bailey DB; Goldman EB; Monaco J; Norgaard-Pedersen B; Terry SF; Johnson A; Howell RR
    Genet Med; 2011 Jul; 13(7):621-4. PubMed ID: 21602691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common criteria among States for storage and use of dried blood spot specimens after newborn screening.
    Petrini C; Olivieri A; Corbetta C; Cerone R; D'Agnolo G; Bompiani A
    Ann Ist Super Sanita; 2012; 48(2):119-21. PubMed ID: 22751553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Policy issues and stakeholder concerns regarding the storage and use of residual newborn dried blood samples for research.
    Rothwell E; Anderson R; Botkin J
    Policy Polit Nurs Pract; 2010 Feb; 11(1):5-12. PubMed ID: 20457727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Blood sampling on paper for neonatal screening. Guidelines for sampling, treatment and preservation of samples. Association française pour le dépistage et la prévention des handicaps de l'enfant (AFDPHE)--Comité d'éthique].
    Arch Pediatr; 1995 Jan; 2(1):3-7. PubMed ID: 7735422
    [No Abstract]   [Full Text] [Related]  

  • 18. MN Supreme Court rules on newborn screening samples.
    Minn Med; 2011 Dec; 94(12):18-9. PubMed ID: 22372040
    [No Abstract]   [Full Text] [Related]  

  • 19. Two faces of patient advocacy: the current controversy in newborn screening.
    Arnold CG
    J Med Ethics; 2014 Aug; 40(8):558-62. PubMed ID: 23592379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parental perspectives on retention and secondary use of neonatal dried bloodspots: a Dutch mixed methods study.
    Jansen ME; van den Bosch LJM; Hendriks MJ; Scheffer MMJ; Heijnen ML; Douglas CMW; van El CG
    BMC Pediatr; 2019 Jul; 19(1):230. PubMed ID: 31288776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.